Pharmaceutical Companies Turn to AI as Drug Development Costs Rise
Artificial intelligence is beginning to change one of the most expensive and uncertain stages of pharmaceutical research: discovering and developing new medicines. Several major pharmaceutical companies are reporting that AI applications have helped reduce the time required for certain early-stage research activities, with some scientists estimating that the process of producing new molecules and advancing…







